|
1
|
Townsend CM Jr, Beauchamp DR and Evers MB:
Sabiston textbook of surgery. 18th. Saunders/Elsevier;
Philadelphia, PA: 2007
|
|
2
|
Kasakura Y, Fujii M, Mochizuki F, Suzuki T
and Takahashi T: Clinicopathological study of brain metastasis in
gastric cancer patients. Surg Today. 30:485–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
York JE, Stringer J, Ajani JA, Wildrick DM
and Gokaslan ZL: Gastric cancer and metastasis to the brain. Ann
Surg Oncol. 6:771–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JL, Kang YK, Kim TW, Chang HM, Lee GW,
Ryu MH, Kim E, Oh SJ, Lee JH, Kim SB, et al: Leptomeningeal
carcinomatosis in gastric cancer. J Neurooncol. 66:167–174. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Go PH, Klaassen Z, Meadows MC and
Chamberlain RS: Gastrointestinal cancer and brain metastasis. A
rare and ominous sign. Cancer. 117:3630–3640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esmaeilzadeh M, Majlesara A, Faridar A,
Hafezi M, Hing B, Esmaeilnia-Shirvani H, Nayazi B, Mehrabi A and
Makamura M: Brain metastasis from gastrointestinal cancers: A
systematic review. Int J Clin Pract. 68:890–899. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cinar P, Calkins SM, Venook AP and Kelley
RK: Case series of patients with HER-2-overexpressed primary
metastatic gastro-esophageal adenocarcinoma. Anticancer Res.
34:7357–7360. 2014.PubMed/NCBI
|
|
8
|
Heitz F, Harter P, Lueck HJ,
Fissler-Eckhoff A, Lorenz-Salehi F, Scheil-Bertram S, Traut A and
du Bois A: Triple negative and HER-2-overexpressing breasts cancers
exhibit an elevated risk and an earlier occurrence of cerebral
metastases. Eur J Cancer. 45:2792–2798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin NU, Bellon JR and Winer EP: CNS
metastases in breast cancer. J Clin Oncol. 22:3608–3617. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin NU, Carey LA, Liu MC, Younger J, Come
SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW,
et al: Phase II trial of lapatinib for brain metastases in patients
with human epidermal growth factor receptor 2-positive breast
cancer. J Clin Oncol. 26:1993–1999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin NU, Diéras V, Paul D, Lossignol D,
Christodoulou C, Stemmler HJ, Roché H, Liu MC, Greil R, Ciruelos E,
et al: Multicenter phase II study of lapatinib in patients with
brain metastases from HER-2-positive breast cancer. Clin Cancer
Res. 15:1452–1459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin NU and Winer EP: Brain metastases: The
HER-2 paradigm. Clin Cancer Res. 13:1648–1655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Preusser M, Capper D, Mutlu IA, Berghoff
AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler
F, et al: Brain metastases: Pathobiology and emerging targeted
therapies. Acta Neuropathol. 123:205–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Musolino A, Ciccolallo L, Panebianco M,
Fontana E, Zanoni D, Bozzetti C, Michiara M, Silini EM and
Ardizzoni A: Multifactorial central nervous system recurrence
susceptibility in patients with HER-2-positive breast cancer.
Cancer May. 1:1837–1846. 2011. View Article : Google Scholar
|
|
15
|
Ross JS, Slodkowska EA, Symmans WF,
Pusztai L, Ravdin PM and Hortobagyi GN: The HER-2 receptor and
breast cancer: Ten years of targeted anti-HER-2 therapy and
personalized medicine. Oncologist. 14:320–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER-2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lei YY, Huang JY, Zhao QR, Jiang N, Xu HM,
Wang ZN, Li HQ, Zhang SB and Sun Z: The clinicopathological
parameters and prognostic significance of HER2 expression in
gastric cancer patients: A meta-analysis of literature. World J
Surg Oncol. 15:682017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kyung WS, Jeon T, Kim S, Kim SS, Kim K,
Suh BJ, Hwang S, Choi S, Ryu S, Min JS, et al: Epidemiologic study
of human epidermal growth factor receptor 2 expression in
advanced/metastatic gastric cancer: An assessment of human
epidermal growth factor receptor 2 status in tumor tissue samples
of gastric and gastro-esophageal junction cancer. J Gastric Cancer.
17:52–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pestalozzi BC, Zahrieh D, Price KN,
Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E,
Pagani O, et al: Identifying breast cancer patients at risk for
central nervous system (CNS) metastases in trials of the
international breast cancer study group (IBCSG). Ann Oncol.
17:935–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choy C, Ansari KI, Neman J, Hsu S, Duenas
MJ, Li H, Vaidehi N and Jandial R: Cooperation of neurotrophin
receptor TrkB and HER-2 in breast cancer cells facilitates brain
metastases. Breast Cancer Res. 19:512017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cavanna L, Rocchi A, Gorgni S, Ambroggi M,
Foroni RP, Ubiali A and Civardi G: Cerebrospinal fluid cytology
diagnosis of HER-2-positive leptomeningeal carcinomatosis from
HER-2-positive metastatic gastric cancer: Case report. J Clin
Oncol. 29:e367–e368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim CH, Shin JE, Roh HG, Lee JS and Yoon
SY: Sudden hearing loss due to internal auditory canal metastasis
of HER-2-positive gastric cancer: A case report. Oncol Lett.
8:394–396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang GL, Luo TH, Zhang HQ, Ling CQ and LI
B: A case report of gastric cancer with brain metastasis: Rare
peripheral nervous system symptoms. Oncol Lett. 11:2893–2895. 2016.
View Article : Google Scholar : PubMed/NCBI
|
